Popular Articles

FDA Approves Feraheme™ To Treat Iron Deficiency Anemia In Adult Chronic Kidney Disease Patients
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Feraheme™ (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. The recommended dose of Feraheme is an initial 510 mg IV injection followed by a second 510 mg IV injection three to eight days later. Feraheme should be administered as an undiluted IV injection delivered at a rate of up to 1 mL/sec (30 mg/sec). The recommended Feraheme dose may be readministered to patients with persistent or recurrent iron deficiency anemia.

Surgical Lessons From The Canadian Field Hospital In Afghanistan
Lessons learned at the Canadian-run military hospital in Kandahar, Afghanistan could help surgeons prepare for civilian disasters, according to a London, Ontario physician who has served two tours at the hospital. Dr. Vivian McAlister is a professor in the Department of Surgery at the Schulich School of Medicine & Dentistry at The University of Western Ontario and a general surgeon at the London Health Sciences Centre. He spent two months working at the Kandahar hospital in 2007 as a civilian surgeon before joining the Canadian Forces and doing a second tour at the hospital this past winter.
News of the day
Obama Administration Calls On Nation To Begin Planning And Preparing For Fall Flu Season & The New H1N1 Virus
The Obama Administration sent a strong message to the nation today that it is time to start planning and preparing for the fall flu season and the ongoing H1N1 flu outbreak and that the federal government is prepared to commit res, training, and new tools to help state and local governments and America"s families get ready.
Oncology

Policymakers To Discuss Alternatives To Custody

Experts in criminology will discuss "Alternatives to Custodial Sentencing" at a Parliamentary seminar organised by the British Psychological Society and the All-Party Parliamentary Group on Social Services and Policy. The event takes place at Westminster on Tuesday 16 June (4.30 - 6.00 p.m.) The seminar will consider the challenges of bringing in alternatives to custody, looking at the relative effectiveness of different approaches, how they could be brought in across the country and the likely public response to such a change. Chaired by Alan Simpson MP, chair of the All-Party Group, the event will include presentations from Prof. Mike Hough, Prof. Julian Roberts and John Samuels QC. Prof. Mike Hough is Professor of Criminal Policy in the School of Law, King"s College London, and Director of the Institute for Criminal Policy. He will argue that the emerging approach, where case managers administrate the provision of support, surveillance and programmes for offenders, risks losing touch with the probation craft of persuading people to change their behaviour. Prof. Julian Roberts is Professor of Criminology at the University of Oxford. His presentation will look at public and professional resistance to community penalties. How strong is this resistance and on what is it based? Can it be overcome by the provision of information on the effectiveness of these penalties? John Samuels QC is chair of the Howard League for Penal Reform"s legal management committee and has sat on the judging panel for its Community Programmes Award for four years. British Psychological Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):